Search
Spotlight
In-person and virtual events just for HCPs
In-person and virtual events just for HCPs
Specialty
View More
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
News
OncClub
All Oncology News
Pipeline Report
OncClub
All Oncology News
Pipeline Report
Media
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Insights
Medical World News
MedNews Week
OncChats
OncLive News Network®
OncLive TV
Peer Exchange
Podcasts
Rapid Readouts
The Talk
Conferences
Conference Coverage
Conference Listing
Conference Coverage
Conference Listing
Events
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Giants of Cancer Care
PER Events
Scientific Interchanges
State of the Science Summit / IPC
Webinars
Partners
Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
Oncology Live®
Oncology Fellows
Supplements and Featured Publications
All Publications
CME/CE
Resources
Interactive Tools
Learning Modules
Presentations
Sponsored
Interactive Tools
Learning Modules
Presentations
Sponsored
Biomarker Consortium
Subscribe
Search
Spotlight
In-person and virtual events just for HCPs
Specialty
See All >
Breast Cancer
Lung Cancer
Gastrointestinal Cancer
Genitourinary Cancers
Ovarian Cancer
Prostate Cancer
Melanoma & Skin Cancer
MCL
MPN
CAR T-cell Therapy
Chronic Lymphocytic Leukemia
Gynecologic Oncology
Hematologic Oncology
Immuno-Oncology
Multiple Myeloma
Urothelial Cancer
Corey J. Langer, MD - Episode 3
Immunotherapy: Potential for Higher Cure Rates in Lung Cancer
October 1, 2015
EP. 1: Looking Ahead to the Next Game-Changer in Lung Cancer
EP. 2: CAR T-Cell Therapy in Lung Cancer
Now Viewing
EP. 3: Immunotherapy: Potential for Higher Cure Rates in Lung Cancer
EP. 4: Applying Immunotherapy Learnings in Melanoma to Lung Cancer
EP. 5: Checkpoint Inhibition Squamous Cell and Nonsquamous Cell NSCLC
EP. 6: Activity of Afatinib in Lung Cancer
EP. 7: LUX-Lung 8: Afatinib Survival Benefit in Squamous NSCLC
EP. 8: Benefits of Liquid Biopsies in Lung Cancer
EP. 9: EGFR-Resistant Disease in Lung Cancer
EP. 10: Role of Gefitinib in EGRF-Mutant NSCLC
EP. 11: Changing Treatment Landscape in Advanced Lung Cancer
Related Content:
Corey J. Langer, MD
Lung Cancer
CAR T-cell Therapy
Dr Jani on the Effects of Tobacco and Air Pollution on Lung Cancer Mortality
Dr Levy on the Clinical Application of ADCs in NSCLC Following ASCO 2024 Data
CD7-Directed CAR T-Cell Therapy WU-CART-007 Is Safe in R/R T-ALL/LBL